RecruitingNCT04093986

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

200 participants

Start Date

Dec 22, 2019

Study Type

OBSERVATIONAL

Conditions

Sickle Cell Disease Sickle Cell Anemia

Summary

The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Chart Review and Survey for people with sickle cell anemia and sickle cell disease. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERChart Review

Medical records or data available from previous clinical care prior to June 20, 2019 about pregnancy and breastfeeding outcomes, both for babies with hydroxyurea exposure and other babies by these same women.

OTHERSurvey

Women who choose to participate directly and provide information in survey format will receive a brief survey and the option to upload their medical records (if available) into Cincinnati Children's maintained REDCap database.